HAGE in triple-negative breast cancer is a novel prognostic, predictive, and actionable biomarker: a transcriptomic and protein expression analysis

Abdel-Fatah, Tarek M.A.; McArdle, Stephanie E.B.; Agarwal, Devika; Moseley, Paul M.; Green, Andrew R.; Ball, Graham R.; Graham Pockley, A.; Ellis, Ian O.; Rees, Robert C.; Chan, Stephen Y.T.

doi:10.1158/1078-0432.CCR-15-0610

HAGE in triple-negative breast cancer is a novel prognostic, predictive, and actionable biomarker: a transcriptomic and protein expression analysis

Abdel-Fatah, Tarek M.A.; McArdle, Stephanie E.B.; Agarwal, Devika; Moseley, Paul M.; Green, Andrew R.; Ball, Graham R.; Graham Pockley, A.; Ellis, Ian O.; Rees, Robert C.; Chan, Stephen Y.T.

Authors

Tarek M.A. Abdel-Fatah

Stephanie E.B. McArdle

Devika Agarwal

Paul M. Moseley

ANDREW GREEN ANDREW.GREEN@NOTTINGHAM.AC.UK
Associate Professor

Graham R. Ball

A. Graham Pockley

Professor IAN ELLIS IAN.ELLIS@NOTTINGHAM.AC.UK
Professor of Cancer Pathology

Robert C. Rees

Stephen Y.T. Chan

Citation

Abdel-Fatah, T. M., McArdle, S. E., Agarwal, D., Moseley, P. M., Green, A. R., Ball, G. R., …Chan, S. Y. (2015). HAGE in triple-negative breast cancer is a novel prognostic, predictive, and actionable biomarker: a transcriptomic and protein expression analysis. Clinical Cancer Research, 22(4), 905-914. https://doi.org/10.1158/1078-0432.CCR-15-0610

Journal Article Type	Article
Acceptance Date	Jul 7, 2015
Publication Date	Aug 5, 2015
Deposit Date	Apr 24, 2018
Print ISSN	1078-0432
Publisher	American Association for Cancer Research
Peer Reviewed	Peer Reviewed
Volume	22
Issue	4
Pages	905-914
DOI	https://doi.org/10.1158/1078-0432.CCR-15-0610
Public URL	https://nottingham-repository.worktribe.com/output/1118156
Publisher URL	http://clincancerres.aacrjournals.org/content/22/4/905
PMID	26240276

Assessment of the Androgen Receptor in Older Women with Primary Breast Cancer: Association with a Panel of Biomarkers and Breast Cancer Specific Survival (2023)
Journal Article

A retrospective analysis of ezrin protein and mRNA expression in breast cancer: Ezrin expression is associated with patient survival and survival of patients with receptor-positive disease (2023)
Journal Article

RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer (2023)
Journal Article

The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development (2022)
Journal Article

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer (2022)
Journal Article

Downloadable Citations

HTML

BIB

RTF

Authors

Citation

You might also like

Downloadable Citations